Cell-based therapies
Wednesday, 10.10.2018 | 08:00 – 09:45 am
| 08:00 – 08:15 am |
Mathias Hoehn (Cologne, Germany) |
In stroke, functional connectivity is stabilised by stem cell graft but structural network responds only to ischemic lesion |
| 08:15 – 08:30 am |
Marcin Majka (Kraków, Poland) |
Multiple autologous bone marrow-derived 271+ mesenchymal stem cells transplantations overcome drug resistant epilepsy in children – a six year study |
| 08:30 – 08:45 am |
Irene Busti (Firenze, Italy) |
Neurons derived from embryonic stem cells extend projections into lesioned brain and promote functional recovery after stroke |
| 08:45 – 09:00 am |
Catriona Cunningham (Manchester, UK) |
Investigating the Role of the Mesenchymal Stem Cell Secretome in Promoting Repair after Ischaemic Stroke |
| 09:00 – 09:15 am |
Liliana Mendonça (Coimbra, Spain) |
Patient-specific iPSC-derived neuroepithelial stem cells for neuroprotection and neuroregeneration in Machado-Joseph disease |
| 09:15 – 09:30 am |
Mari Carmen Gómez de Frutos (Madrid, Spain) |
A dose-response in vitro of extracellular vesicles to evaluate their efficacy in an animal model of subcortical stroke |
| 09:30 – 09:45 am |
Alba Grayston (Barcelona, Spain) |
Encapsulating Endothelial Progenitor Cell secretome in magnetized biocompatible nanocapsules for targeted cell-free therapy for neurorepair after stroke |